Loading clinical trials...
Loading clinical trials...
The Impact of the Use of Recombinant Human Growth Hormone on Attention Hyperactivity Deficit Characteristics in Children and Adolescents
Conditions
Interventions
Questionnaires
Locations
1
Israel
Assaf Haroffeh Medical center
Zrifin, Israel
Start Date
January 1, 2015
Primary Completion Date
December 1, 2024
Completion Date
December 1, 2024
Last Updated
August 9, 2022
NCT07478458
NCT06382155
NCT06655610
NCT07333521
NCT07412782
NCT00227253
Lead Sponsor
Assaf-Harofeh Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions